Status:
TERMINATED
Assessment of Performance of [18F]-FES for Endometriosis Diagnosis
Lead Sponsor:
University Hospital, Angers
Conditions:
Endometriosis
Eligibility:
FEMALE
18-50 years
Phase:
PHASE2
Brief Summary
Endometriosis is a benign chronic disease responsible for infertility and pelvic pain. One of the main problem of endometriosis is the significant delay of diagnosis.This delay has significant consequ...
Eligibility Criteria
Inclusion
- First planned coelioscopy (therapeutic indication) for suspected endometriosis
- Patient aged from 18 to 50 years
- Absence of treatment with GnRH (gonadotropin-releasing hormone) analogue for at least 3 months
- Patient affiliated to a social security system
- No hormonal treatment for at least 3 months
Exclusion
- History of abdominal pelvic surgery for endometriosis
- Current treatment with GnRH (gonadotropin-releasing hormone) or stopped for less than 3 months
- hormonal Drug ongoing
- Patient pregnant, may be or during lactation
- Patient under guardianship or trusteeship
- Patient unable to understand the purpose of the study
- Patient already included in another clinical trial with an experimental molecule.
Key Trial Info
Start Date :
June 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 6 2016
Estimated Enrollment :
31 Patients enrolled
Trial Details
Trial ID
NCT02233621
Start Date
June 1 2012
End Date
April 6 2016
Last Update
September 17 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nuclear medicin unit, University Hospital of Angers
Angers, France, 49933